Day One Biopharmaceuticals, Inc. (DAWN) Operating Lease, Right-of-Use Asset USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Day One Biopharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2020 to 2024.
  • Day One Biopharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $259 K, a 58% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $259 K -$357 K -58% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $352 K -$347 K -49.6% Dec 31, 2023 10-Q 2024-05-06
Q3 2023 $442 K -$422 K -48.8% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $530 K -$463 K -46.6% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $616 K +$436 K +242% Mar 31, 2023 10-Q 2023-05-01
Q4 2022 $699 K +$472 K +208% Dec 31, 2022 10-K 2024-02-26
Q3 2022 $864 K +$591 K +216% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $993 K +$674 K +211% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $180 K Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $227 K -$179 K -44.1% Dec 31, 2021 10-K 2023-03-06
Q3 2021 $273 K Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $319 K Jun 30, 2021 10-Q 2021-08-10
Q4 2020 $406 K Dec 31, 2020 10-K 2022-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.